118th Congress · SENATE BILLINCORPORATED

S. 1280Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023

A bill to require coordinated National Institute of Standards and Technology science and research activities regarding illicit drugs containing xylazine, novel synthetic opioids, and other substances of concern, and for other purposes.

Science, technology, communications
Introduced Apr 25, 2023
Last action Dec 13, 2023
Pipeline · Bill → Law
Step 1
Introduced
Apr 25, 2023
Step 2
Referred
Apr 25, 2023
Commerce, Science, and Transportation
Step 3
Committee
May 10, 2023
Reported out
Step 4
Senate
Dec 13, 2023
Step 5
House floor
Step 6
Resolve Changes
Step 7
Signed
SummaryCRS Summary

This bill requires the National Institute of Standards and Technology (NIST) to support research and other activities related to identifying xylazine (a compound used in veterinary medicine as a nonopioid tranquilizer), novel synthetic opioids, and other new psychoactive substances. In particular, NIST must support basic measurement science and research, including graduate and postgraduate research; near-real time spectrometry capabilities (i.e., a technique for rapidly identifying the chemical composition of a substance); strategies and voluntary best practices for handling, transporting, and analyzing such substances; and collaboration with other government agencies, institutions of hig...

Provisions · 2 sectionsReported to Senate
Similar Bills · 1 matches
BillText overlapStatus
H.R. 1734Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023
51%
ENACTED
Timeline · 5 actions
Dec 13, 2023
Committee on Commerce, Science, and Transportation. Reported by Senator Cantwell with an amendment in the nature of a substitute. Without written report.
Dec 13, 2023
Placed on Senate Legislative Calendar under General Orders. Calendar No. 286.
May 10, 2023
Committee on Commerce, Science, and Transportation. Ordered to be reported with an amendment in the nature of a substitute favorably.
Apr 25, 2023
Introduced in Senate
Apr 25, 2023
Read twice and referred to the Committee on Commerce, Science, and Transportation.